All leading centres at UCL including the Multiple Sclerosis NMR Research Unit, Dementia Research Centre, Epilepsy Research Group, Neuroradiological Academic Unit, WTCN, MRC Centre for Neuromuscular diseases, Birkbeck-UCL Centre for Neuroimaging and CMIC have identified their key aims for the next 5 years: 1) obtaining insights into key pathogenetic mechanisms common to multiple neurological and neuromuscular diseases, stratified to provide benefit to individual patients 2) developing and testing imaging biomarkers that will serve as outcome measures to clinical trials in MS, AD, epilepsy, cerebrovascular, neuro-oncology, and neuromuscular diseases. These areas provide unique opportunities for engineers to make a clinical impact.

Theme Leader: Dr Olga Ciccarelli

Page last modified on 01 dec 13 21:55